AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 206 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $260,167 | -21.7% | 4,527 | -48.9% | 0.03% | -25.6% |
| Q1 2023 | $332,437 | +28.1% | 8,865 | -4.3% | 0.04% | +14.7% |
| Q4 2022 | $259,465 | -6.7% | 9,260 | -6.3% | 0.03% | -17.1% |
| Q3 2022 | $278,000 | -19.0% | 9,878 | +0.3% | 0.04% | -14.6% |
| Q2 2022 | $343,000 | +0.3% | 9,846 | +3.3% | 0.05% | +14.3% |
| Q1 2022 | $342,000 | +53.4% | 9,535 | -0.3% | 0.04% | +44.8% |
| Q4 2021 | $223,000 | -7.5% | 9,565 | -20.0% | 0.03% | -19.4% |
| Q2 2021 | $241,000 | +10.6% | 11,949 | +0.3% | 0.04% | -37.9% |
| Q1 2021 | $218,000 | -6.4% | 11,913 | +2.8% | 0.06% | -7.9% |
| Q4 2020 | $233,000 | – | 11,592 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Campbell & CO Investment Adviser LLC | 11,961 | $219,000 | 0.13% |
| FEDERATED HERMES, INC. | 3,441,367 | $63,046,000 | 0.12% |
| CORNERCAP INVESTMENT COUNSEL INC | 54,751 | $1,003,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 34,425 | $631,000 | 0.10% |
| First Trust Direct Indexing L.P. | 11,913 | $218,000 | 0.06% |
| Summit Global Investments | 47,546 | $871,000 | 0.06% |
| WINTON GROUP Ltd | 49,766 | $912,000 | 0.05% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 397,950 | $7,290,000 | 0.05% |
| AIGEN INVESTMENT MANAGEMENT, LP | 16,077 | $295,000 | 0.04% |
| EXCHANGE TRADED CONCEPTS, LLC | 52,334 | $959,000 | 0.04% |